In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

The patented platform combines high-quality genome sequencing, rigorous quality control, biologically informed methylation ...

Reliance's Strand Life Sciences has been granted an Indian patent for its platform enabling early cancer detection from a ...

Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...

Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...

Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...

A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

We're on the cusp of a new era in cancer care – one that could dramatically improve survival and quality of life.

For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could ...